Sep 30, 2017

ANI Pharmaceuticals Q3 2017 Earnings Report

Total Revenue
$48.2M
Previous year: $38.5M
+25.0%
EPS
$1.11
Previous year: $1.09
+1.8%
Gross Profit
$27.1M
Previous year: $21.9M
+23.9%
Cash and Equivalents
$18M
Previous year: $16.2M
+11.6%
Free Cash Flow
$14.6M
Previous year: -$5K
-292180.0%
Total Assets
$370M
Previous year: $319M
+16.0%

ANI Pharmaceuticals

ANI Pharmaceuticals